Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

A new study suggests that men with inflammatory bowel disease (IBD) may face a significantly higher risk of developing heart disease over time.

Severe abdominal pains, unpredictable bowel movements and fatigue are some of the serious symptoms 180,000 Australians live ...

Not all fiber is created equal when it comes to gut issues. Certain fiber types can provoke symptoms, while others aid in ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

“When patients have a flare-up of Crohn’s, they can have anemia,” says William Sandborn, MD, the chief of gastroenterology and the director of the inflammatory bowel disease center at the ...

The Levy family is excited to be recognized as the 2025 New England Take Steps Honored Family, and Soliel as the Honored Hero ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.